[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IL149367A0 - Method and compositions for treating pulmonary diseases - Google Patents

Method and compositions for treating pulmonary diseases

Info

Publication number
IL149367A0
IL149367A0 IL14936700A IL14936700A IL149367A0 IL 149367 A0 IL149367 A0 IL 149367A0 IL 14936700 A IL14936700 A IL 14936700A IL 14936700 A IL14936700 A IL 14936700A IL 149367 A0 IL149367 A0 IL 149367A0
Authority
IL
Israel
Prior art keywords
compositions
pulmonary diseases
treating pulmonary
treating
diseases
Prior art date
Application number
IL14936700A
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of IL149367A0 publication Critical patent/IL149367A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL14936700A 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases IL149367A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02
PCT/US2000/030113 WO2001032127A2 (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases

Publications (1)

Publication Number Publication Date
IL149367A0 true IL149367A0 (en) 2002-11-10

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14936700A IL149367A0 (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases

Country Status (29)

Country Link
EP (1) EP1225866A4 (en)
JP (1) JP2003513028A (en)
KR (1) KR20020057988A (en)
CN (1) CN1387404A (en)
AP (1) AP2002002496A0 (en)
AR (1) AR029189A1 (en)
AU (1) AU1357501A (en)
BG (1) BG106748A (en)
BR (1) BR0015270A (en)
CA (1) CA2388333A1 (en)
CO (1) CO5261512A1 (en)
CZ (1) CZ20021512A3 (en)
DZ (1) DZ3225A1 (en)
EA (1) EA200200518A1 (en)
EC (1) ECSP003747A (en)
HK (1) HK1049107A1 (en)
HU (1) HUP0203152A3 (en)
IL (1) IL149367A0 (en)
MA (1) MA26841A1 (en)
MX (1) MXPA02004350A (en)
NO (1) NO20022057L (en)
OA (1) OA12076A (en)
PE (1) PE20011005A1 (en)
PL (1) PL355261A1 (en)
SK (1) SK7592002A3 (en)
TR (1) TR200201211T2 (en)
TW (1) TWI242431B (en)
WO (1) WO2001032127A2 (en)
ZA (1) ZA200203435B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003024489A2 (en) 2001-09-19 2003-03-27 Altana Pharma Ag Combination of a nsaid and a pde-4 inhibitor
US20040259863A1 (en) * 2001-10-31 2004-12-23 Hans-Michael Eggenweiler Type 4 phosphodiesterase inhibitors and uses thereof
UA82323C2 (en) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Novel combination of a glucocorticoid and pde-inhibitor for the treatment of respiratory diseases, allergic diseases, asthma and chronic obstructive pulmonary diseases
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
EP1616569A1 (en) * 2003-03-31 2006-01-18 Kyowa Hakko Kogyo Co., Ltd. Medicinal composition
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20070287689A1 (en) * 2004-10-13 2007-12-13 Kyowa Hakko Kogyo Co., Ltd. Therapeutic And/Or Preventive Agents For Chronic Skin Diseases
EP1948167A1 (en) * 2005-10-19 2008-07-30 Ranbaxy Laboratories, Ltd. Compositions of phosphodiesterase type iv inhibitors
JP6017961B2 (en) 2010-01-05 2016-11-02 マイクロドース セラピューテクス,インコーポレイテッド Inhalation device and method
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7174794A (en) * 1993-06-18 1995-01-17 Smithkline Beecham Corporation Compounds
DE4332041C2 (en) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Use of pentoxifylline in certain lung diseases
PE44995A1 (en) * 1994-01-27 1995-12-18 Schering Corp MOMETASONE FUROATE FOR THE TREATMENT OF LUNG DISEASES AND RESPIRATORY TRACT
SE9801368D0 (en) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
PL355261A1 (en) 2004-04-05
NO20022057L (en) 2002-06-27
TR200201211T2 (en) 2002-08-21
NO20022057D0 (en) 2002-04-30
AP2002002496A0 (en) 2002-06-30
EP1225866A2 (en) 2002-07-31
HUP0203152A2 (en) 2003-01-28
CN1387404A (en) 2002-12-25
BG106748A (en) 2003-02-28
EA200200518A1 (en) 2002-10-31
BR0015270A (en) 2002-06-18
CA2388333A1 (en) 2001-05-10
ECSP003747A (en) 2002-05-23
TWI242431B (en) 2005-11-01
MXPA02004350A (en) 2002-11-07
AR029189A1 (en) 2003-06-18
JP2003513028A (en) 2003-04-08
CZ20021512A3 (en) 2003-04-16
DZ3225A1 (en) 2001-05-10
SK7592002A3 (en) 2002-11-06
HK1049107A1 (en) 2003-05-02
WO2001032127A3 (en) 2001-12-06
PE20011005A1 (en) 2001-09-28
EP1225866A4 (en) 2004-04-21
AU1357501A (en) 2001-05-14
CO5261512A1 (en) 2003-03-31
KR20020057988A (en) 2002-07-12
WO2001032127A2 (en) 2001-05-10
OA12076A (en) 2006-05-04
HUP0203152A3 (en) 2004-06-28
ZA200203435B (en) 2003-06-25
MA26841A1 (en) 2004-12-20

Similar Documents

Publication Publication Date Title
IL142132A0 (en) Methods and compositions for treating receptor mediated diseases
EP1416961A4 (en) Composition and method for the treatment of disease
HK1048949A1 (en) Method and composition for the treatment of scars
AU2002219945A1 (en) Composition and method for treating snoring
HU0001471D0 (en) New method of treatment
AP2000002010A0 (en) Novel pharmaceutical compositions for treating and saving and the methods for the preparation thereof
EP1109548A4 (en) Compositions and methods for treating and preventing bone diseases using tocotrienols
HU0001629D0 (en) Method for treating plants and compositions for it
AU2002367023A8 (en) Compositions and methods for treating heart failure
AU2002365057A8 (en) Compositions and methods for treating heart failure
HUP0203152A3 (en) Method and compositions for treating pulmonary diseases
IL150963A0 (en) Method and compositions for treating an inflammatory disease
EP1234869A4 (en) Cleaning composition and method for preparing the same
AU4515001A (en) Compositions and methods for locally treating inflammatory diseases
AU6137801A (en) Method and composition for the treatment of angiogenesis
EP1261331A4 (en) Method and compositions for treating fibrotic diseases
HUP0101326A3 (en) Paroxetine compositions and process for their preparation
EP1349548A4 (en) Methods and compositions for treating periodontal disease
AU2002342188A8 (en) Methods and compositions for treating flavivirus-mediated disease
IL138654A0 (en) Methods and materials for treating inflammatory diseases
EP1173159A4 (en) Composition and method useful for treating colic
EP1397507A4 (en) Methods and compositions for treating cardiovascular disease using 10218
GB0024961D0 (en) Compositions and methods for treating respiratory disease
GB9917409D0 (en) Composition and method
GB9929493D0 (en) Composition and method